Saudi Food and Drug Authority (SFDA) has issued a safety alert on the continuous positive airway pressure (CPAP) devices for the treatment of sleep apnea, manufactured by Philips Respironics in the United States of America .
SFDA stated that the affected medical devices, which included a problem related to the sound-reducing material used in it, are the devices that were manufactured before April 26, 2021, which included 24 affected models.
SFDA urge users of these affected models to contact the authorized representative of Philips Respironics to complete the corrective action and thinspect / replace it by calling e direct line 8008140039.
SFDA advises medical devices' users to report any incident/adverse events or problems suspected of being related to medical devices through SFDA’s reporting channels which are: 
Unified call center on the number (19999)